Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2084 of 6351
-
Your voice could reveal hidden cancer: AI listens for signs
Diagnosis CompletedParticipants diagnosed with oral cancer, oropharyngeal cancer, or oral potentially malignant lesions, as well as healthy controls, had their speech audio recordings collected for the development and validation of AI-driven models for diagnosis and prognosis prediction of oral can…
Sponsor: Yudong Xiao • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Could a seizure drug curb alcohol withdrawal in trauma wards?
Disease control Stopped earlyAlcohol use disorder, or heavy drinking, is commonly seen in patients who present to trauma centers. These patients are at risk for Alcohol Withdrawal Syndrome (AWS), which is collection of symptoms that can range from anxiety and restlessness to seizures, delirium and even death…
Phase 4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo therapy targets advanced lung cancer after relapse
Disease control CompletedThis is an open label, multi-institutional, single arm study with a dose escalation phase Ib cohort, followed by a phase II cohort of pembrolizumab and Imprime PGG. No randomization or blinding is involved.
Phase 1/2 • Sponsor: Lawrence Feldman, MD • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a common painkiller replace ibuprofen for preemie heart treatment?
Disease control CompletedMulticentric, double-blind clinical trial, which will evaluate the efficacy of iv paracetamol versus standard treatment with ibuprofen in the closure of patent ductus arteriosus in the preterm newborn. Secondarily, we intend to compare the safety of both treatments, increase our …
Phase 3 • Sponsor: Máximo Vento Torres • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Tailoring chemo by genetics and health may boost survival in older AML patients
Disease control CompletedAcute myeloid leukemia (AML) is among the most common hematologic malignancies in adults and accounts for approximately 10,000 deaths in the United States every year. AML is commonly diagnosed in sixth or seventh decades of life. The management of AML is complex in older patients…
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Ear acupuncture tested as pain relief for breast cancer survivors
Symptom relief CompletedAuriculotherapy is a complementary medicine, with few side effects, without contraindication, inexpensive and not very restrictive.Its efficacy has been found in several tests especially for the treatment of intraoperative pain. It remains more controversial in other indications.…
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jun 26, 2026 15:33 UTC
-
Can alcohol and cannabis together worsen driving skills more than either alone?
Knowledge-focused CompletedAlcohol and cannabis are the two most widely used substances of abuse in the world and are the psychoactive substances most often found in seriously and fatally injured drivers. In a recent study, it was observed that individuals who reported both driving under the influence of a…
Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can speech therapy slow language loss in progressive aphasia?
Symptom relief OngoingPrimary progressive aphasia (PPA) is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurodegeneration of speech and language networks in the brain. PPA is a devastating condition affecting adults as young as the…
Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Potassium pills may slow kidney decline in CKD patients
Disease control OngoingThe current high-sodium, low-potassium diet contributes to the high prevalence of high blood pressure (hypertension). Indeed, the anti-hypertensive effects of potassium supplementation are well-established. Hypertension is even more prevalent and resistant in patients with chroni…
Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can radiation wake up the immune system against resistant head and neck cancer?
Disease control OngoingThis research study is studying immunotherapy in combination with radiation therapy as a possible treatment for head \& neck cancer that has worsened or spread to another organ or part of your body. The immunotherapy involved in this study is: MK-3475 (pembrolizumab or KEYTRUDA)…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill shows promise for Hard-to-Treat blood cancers in japanese patients
Disease control CompletedThis is a multicenter, open-label Phase 1 study of acalabrutinib, a selective and irreversible Bruton's tyrosine kinase inhibitor, in Japanese adult patients with advanced B-cell malignancies. This study is divided into 3 parts: Part 1 (dose-confirmation phase), Part 2 (dose-expa…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Experimental combo targets tough blood cancers
Disease control Recruiting nowThis research study is studying a drug as a possible treatment for diagnosis of AML, BPDCN and high-risk MDS. The interventions involved in this study are: * SL-401 * Azacitidine * Venetoclax
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can continued therapy keep OCD symptoms at bay?
Disease control OngoingThe purpose of this study is to provide participants diagnosed with obsessive compulsive disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with open/aftercare treatment.
Sponsor: Stanford University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a Pre-Transplant HPV shot shield patients from cancer?
Disease control OngoingThis phase II trial studies whether the nonavalent human papillomavirus vaccine given to adults prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Coordinated care after fracture could save bones and lives
Disease control By invitation onlyAims: To compare clinical outcomes for patients under FLS and usual care at the NTUH MH and BB. Method: Four hundred subjects with new hip fracture or newly identified vertebral fracture are randomly assigned into FLS and usual care (UC). FLS subjects received osteoporosis-relat…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Statin drug tested to stop liver cancer in cirrhosis patients
Disease control CompletedThis phase II trial studies how well simvastatin works in preventing liver cancer in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New drug shows promise for taming involuntary movements
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy and safety of MT-5199 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.
Phase 2/3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Blood 'bath' with light may stop transplant complication
Disease control CompletedThe main aim is to test the preventive use of extracorporeal photophoresis (ECP) against development of graft-versus-host disease (GVHD) in patients undergoing allogeneic stem cell transplantation for hematological malignancy.
Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New stem cell transplant approach aims to tame deadly bone marrow cancer
Disease control OngoingThis pilot phase I trial studies the side effects of combination chemotherapy, total body irradiation, and donor blood stem cell transplant in treating patients with secondary myelofibrosis. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, eit…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New chip could pick healthier sperm for IVF
Disease control CompletedThis is a randomized controlled trial of couples with a history of poor embryo quality undergoing a repeat in vitro fertilization (IVF) cycle for unexplained infertility. Couples will be randomized to sperm selection by the clinical standard of centrifugation and density-gradient…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC